← All patents

US20250186451A1

Methods of treating cancer with iap antagonist compounds and combination …

University of Texas System

Abstract

The present disclosure relates generally to use of a compound of formula (I), also named ASTX660 in combination therapies for treating cancer, in particular leukemia.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Martin John Sims
Priority date
March 04, 2022
Filing date
March 03, 2023
Publication date
June 12, 2025
Language
en
Metadata fetched
August 29, 2026 00:34